cl en false false

China – Growth Weakness vs. Market Optimism

30 November 2022

Read Time 2 MIN

China’s pre-emptive moves to ease some COVID restrictions and support real estate developers are the reasons why the market chose to look through surprisingly weak domestic activity gauges.

China Slowdown

China’s domestic activity gauges for November were bad, no question about it. Most indices were well in contraction zone and deteriorating (see chart below). Even the construction PMI1 (Purchasing Managers Index) – which benefited from the earlier infrastructure stimulus – eased from 58.2 to 55.4. So, why is the market choosing to downplay the weakness? The answer is that authorities made several pre-emptive policy moves before the release, and, importantly, these initiatives address the underlying reasons of the slowdown – primarily real estate and re-opening. 

China Real Estate Developers

The re-opening is still very tentative – the 20-point plan focuses on the optimization of the pandemic control, quarantine times, the frequency of testing and risk area delineations – but support for property developers looks more solid. The real estate package includes “stable financing” (the resumption of equity funding for listed companies, bond issuance, “reasonable” loan extension, relending facilities and absolving lenders from personal responsibility if something goes wrong), equal treatment of state-owned and private developers and mortgage support for homebuyers. Given the foregoing, it is not surprising that China’s High Yield/developers’ bonds staged a nice rally in the past week or so.

China Growth – Global Implications

One problem that China cannot fix on its own is weakening global demand – the new export orders PMI dropped to 46.7, which is the lowest level since May. “2023 Growth Cliff” is the most likely scenario for China’s main trade partners, and this underscores the importance of domestic pro-growth policies and orderly re-opening. Earlier reports about vaccination plans for the elderly and the easing of COVID restrictions in Guangzhou look encouraging, even though the progress will probably be slow and uneven (despite assertions that the anti-lockdown protests might turn out “stimulative”). The prospect of China’s domestic rebound – and commodity prices’ reaction to it – raises some interesting questions about (a) global disinflation and (b) growth spillovers in emerging markets (EM) (especially for commodity exporters). But this might be a story for Q2-Q3 next year. Stay tuned!

Chart at a Glance: China Activity Gauges – Still Sliding Down

Chart at a Glance: China Activity Gauges - Still Sliding Down

Source: Bloomberg LP.

1 We believe PMIs are a better indicator of the health of the Chinese economy than the gross domestic product (GDP) number, which is politicized and is a composite in any case. The manufacturing and non-manufacturing, or service, PMIs have been separated in order to understand the different sectors of the economy. These days, we believe the manufacturing PMI is the number to watch for cyclicality.

IMPORTANT DEFINITIONS & DISCLOSURES  

This material may only be used outside of the United States.

This is not an offer to buy or sell, or a recommendation of any offer to buy or sell any of the securities mentioned herein. Fund holdings will vary. For a complete list of holdings in VanEck Mutual Funds and VanEck ETFs, please visit our website at www.vaneck.com.

The information presented does not involve the rendering of personalized investment, financial, legal, or tax advice. Certain statements contained herein may constitute projections, forecasts and other forward looking statements, which do not reflect actual results. Information provided by third-party sources are believed to be reliable and have not been independently verified for accuracy or completeness and cannot be guaranteed. Any opinions, projections, forecasts, and forward-looking statements presented herein are valid as of the date of this communication and are subject to change without notice. The information herein represents the opinion of the author(s), but not necessarily those of VanEck.

The views contained herein are not to be taken as advice or a recommendation to buy or sell any investment in any jurisdiction, nor is it a commitment from Van Eck Associates Corporation or its subsidiaries to participate in any transactions in any companies mentioned herein. This content is published in the United States. Investors are subject to securities and tax regulations within their applicable jurisdictions that are not addressed herein.

All investing is subject to risk, including the possible loss of the money you invest. As with any investment strategy, there is no guarantee that investment objectives will be met and investors may lose money. Diversification does not ensure a profit or protect against a loss in a declining market. Past performance is no guarantee of future results.